These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15171255)

  • 1. Dynamics of the p53 acetylation pathway.
    Gu W; Luo J; Brooks CL; Nikolaev AY; Li M
    Novartis Found Symp; 2004; 259():197-205; discussion 205-7, 223-5. PubMed ID: 15171255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.
    Ito A; Lai CH; Zhao X; Saito S; Hamilton MH; Appella E; Yao TP
    EMBO J; 2001 Mar; 20(6):1331-40. PubMed ID: 11250899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation.
    Ito A; Kawaguchi Y; Lai CH; Kovacs JJ; Higashimoto Y; Appella E; Yao TP
    EMBO J; 2002 Nov; 21(22):6236-45. PubMed ID: 12426395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins.
    Kobet E; Zeng X; Zhu Y; Keller D; Lu H
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12547-52. PubMed ID: 11070080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of p53 degradation by Mdm2 acetylation.
    Wang X; Taplick J; Geva N; Oren M
    FEBS Lett; 2004 Mar; 561(1-3):195-201. PubMed ID: 15013777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.
    Wang C; Ivanov A; Chen L; Fredericks WJ; Seto E; Rauscher FJ; Chen J
    EMBO J; 2005 Sep; 24(18):3279-90. PubMed ID: 16107876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deacetylation of p53 modulates its effect on cell growth and apoptosis.
    Luo J; Su F; Chen D; Shiloh A; Gu W
    Nature; 2000 Nov; 408(6810):377-81. PubMed ID: 11099047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDMX inhibits the p300/CBP-mediated acetylation of p53.
    Sabbatini P; McCormick F
    DNA Cell Biol; 2002 Jul; 21(7):519-25. PubMed ID: 12162806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis.
    Tang Y; Luo J; Zhang W; Gu W
    Mol Cell; 2006 Dec; 24(6):827-39. PubMed ID: 17189186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acidic domain is indispensable for MDM2 to negatively regulate the acetylation of p53.
    Wang Q; Yang Y; Wang L; Zhang PZ; Yu L
    Biochem Biophys Res Commun; 2008 Sep; 374(3):437-41. PubMed ID: 18638452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIAH-mediated ubiquitination and degradation of acetyl-transferases regulate the p53 response and protein acetylation.
    Grishina I; Debus K; García-Limones C; Schneider C; Shresta A; García C; Calzado MA; Schmitz ML
    Biochim Biophys Acta; 2012 Dec; 1823(12):2287-96. PubMed ID: 23044042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity.
    Mizuguchi Y; Specht S; Lunz JG; Isse K; Corbitt N; Takizawa T; Demetris AJ
    BMC Mol Biol; 2012 Jun; 13():20. PubMed ID: 22731250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
    Grönroos E; Terentiev AA; Punga T; Ericsson J
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12165-70. PubMed ID: 15295102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation.
    Koumenis C; Alarcon R; Hammond E; Sutphin P; Hoffman W; Murphy M; Derr J; Taya Y; Lowe SW; Kastan M; Giaccia A
    Mol Cell Biol; 2001 Feb; 21(4):1297-310. PubMed ID: 11158315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To die or not to die: a HAT trick.
    Tyteca S; Legube G; Trouche D
    Mol Cell; 2006 Dec; 24(6):807-8. PubMed ID: 17189182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylases specifically down-regulate p53-dependent gene activation.
    Juan LJ; Shia WJ; Chen MH; Yang WM; Seto E; Lin YS; Wu CW
    J Biol Chem; 2000 Jul; 275(27):20436-43. PubMed ID: 10777477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p53 response to DNA damage.
    Meek DW
    DNA Repair (Amst); 2004; 3(8-9):1049-56. PubMed ID: 15279792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylation of Sirt2 by p300 attenuates its deacetylase activity.
    Han Y; Jin YH; Kim YJ; Kang BY; Choi HJ; Kim DW; Yeo CY; Lee KY
    Biochem Biophys Res Commun; 2008 Oct; 375(4):576-80. PubMed ID: 18722353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of p53 acetylation, stability and function by an oncogenic transcription factor.
    Insinga A; Monestiroli S; Ronzoni S; Carbone R; Pearson M; Pruneri G; Viale G; Appella E; Pelicci P; Minucci S
    EMBO J; 2004 Mar; 23(5):1144-54. PubMed ID: 14976551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of p53 and MDM2 activity by MTBP.
    Brady M; Vlatkovic N; Boyd MT
    Mol Cell Biol; 2005 Jan; 25(2):545-53. PubMed ID: 15632057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.